Table 3. Cox regression model: variables as predictors of cardiovascular mortality.
| UNIVARIAT ANALYSIS | MULTIVARIAT ANALYSIS | |||||||
|---|---|---|---|---|---|---|---|---|
| p | HR | 95.0% CI for HR | P | HR | 95.0% CI for HR | |||
| Lower | Upper | Lower | Upper | |||||
| Age | .0510 | 1.057 | 1.000 | 1.118 | .586 | 1.017 | .956 | 1.082 |
| Gender | .310 | .635 | .264 | 1.526 | ||||
| Hypertension | .644 | .787 | .285 | 2.172 | ||||
| Diabetes mellitus | .949 | .971 | .387 | 2.433 | ||||
| Hyperlipidemia | .087 | .463 | .192 | 1.118 | ||||
| Smoking | .280 | .330 | .044 | 2.464 | ||||
| Coronary artery disease | .039 | 2.744 | 1.054 | 7.140 | .115 | 2.179 | .826 | 5.747 |
| EPC | .034 | 2.818 | 1.082 | 7.338 | .026 | 3.074 | 1.146 | 8.243 |
| Hemoglobin (g/dL) | .225 | .845 | .643 | 1.109 | ||||
| White blood cells (K/ul) | .094 | .814 | .640 | 1.035 | ||||
| Platelets (K/ul) | .091 | .993 | .986 | 1.001 | ||||
| Protein (g/dL) | .580 | .822 | .410 | 1.647 | ||||
| Albumin (g/dL) | .785 | .864 | .303 | 2.464 | ||||
| Ca+(mg/dL) | .177 | .619 | .309 | 1.242 | ||||
| LDL (mg/dL) | .482 | 1.005 | .990 | 1.020 | ||||
| LVEDD (mm) | .716 | .985 | .909 | 1.068 | ||||
| LVESD (mm) | .913 | .994 | .895 | 1.104 | ||||
| LV mass (g) | .264 | 1.004 | .997 | 1.011 | ||||
| LVEF (%) | .913 | .994 | .895 | 1.104 | ||||
| Peak AV gradient (mmHG) | .055 | 1.013 | 1.000 | 1.027 | ||||
| Mean AV gradient (mmHG) | .085 | 1.019 | .997 | 1.041 | ||||
| AS severity index | 0.005 | 1.831 | 1.196 | 2.803 | 0.037 | 1.785 | 1.035 | 3.077 |
| AVA (cm2) | .005 | .038 | .004 | .372 | ||||
| PAP (mmHG) | .043 | 1.029 | 1.001 | 1.058 | ||||
| NYHA class | .022 | 3.058 | 1.175 | 7.961 | ||||
LDL low density cholesterol, LVEDD-left ventricular end diastolic diameter, LVESD-Left ventricular end systolic diameter, LVEF-left ventricular ejection fraction, AV-aortic valve, AVA aortic valve area, PAP pulmonary artery press